Home
REVA Medical

REVA Medical Market Share Analysis for May 2026

REVA is a leader in bioresorbable polymer technologies for vascular applications. Learn about the Fantom bioresorbable scaffold. Contact info@revamedical.com.

Industry: N/A

Domainrevamedical.com

Year Founded1998

Employees51 - 200

Annual Revenue$15M - $25M

REVA Medical

REVA Medical (including company regionals)

revamedical.com

See more website traffic and engagement information

REVA Medical Revenue up to May 2026 is 15M - 25M

revenue generated by REVA Medical top domains

REVA Medical top domains revenue over 3 years

Revenue for REVA Medical top domains

revamedical.com15M - 25M

See more with Sales Intelligence

Total visits to REVA Medical's top domains

Understand REVA Medical market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

revamedical.com2.2K

See more with Sales Intelligence

Avg. visit duration in REVA Medical's top domains

Analyze REVA Medical engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

revamedical.com00:00:40

See more with Sales Intelligence

Avg. pageviews on REVA Medical's top domains

See how REVA Medical keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

revamedical.com1.95

See more with Sales Intelligence

REVA Medical top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by REVA Medical

These are the website technologies, by industry, used by REVA Medical top domains

Content Management System (3)

WordPress

Conversion & Analytics (3)

Google Analytics

Widget (3)

Google Maps

Email Services (2)

Microsoft Exchange Online

More Technologies

8

See all

News & Signals from REVA Medical

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsREVA Medical, Inc. receives financing of $45M in Series B.In August, REVA announced the closing of a $45 million Series B equity financing in support of its clinical program for the MOTIV scaffold.

NewsREVA Medical, Inc. decreased headcount by 22 on Feb 1st '19.In February 2019, Reva announced its plans to cut its workforce by 44%, leaving 22 employees remaining at the company at that time.

NewsREVA Medical, Inc. hired Leigh Elkolli as Senior Director of Finance and Corporate Controller on Aug 1st '17.On January 14, 2019, Reva Medical, Inc. (the “Company”) entered into an executive employment agreement (the “Agreement”) with Leigh Elkolli, the Company’s newly appointed Chief Financial Officer, effective as of the date of her appointment.